<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="029753-2018" EDITION="2018014"><TECHNICAL_SECTION><RECEPTION_ID>18-028912-001</RECEPTION_ID><DELETION_DATE>20180428</DELETION_DATE><FORM_LG_LIST>EN </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>14</NO_OJ><DATE_PUB>20180120</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 014-029753</NO_DOC_OJS><URI_LIST><URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:029753-2018:TEXT:EN:HTML</URI_DOC></URI_LIST><LG_ORIG>EN</LG_ORIG><ISO_COUNTRY VALUE="UK"/><IA_URL_GENERAL>https://cmu.bravosolution.co.uk</IA_URL_GENERAL><IA_URL_ETENDERING>https://cmu.bravosolution.co.uk</IA_URL_ETENDERING><ORIGINAL_CPV CODE="33651660">Influenza vaccines</ORIGINAL_CPV><ORIGINAL_CPV CODE="33651600">Vaccines</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="UK">UNITED KINGDOM</n2016:PERFORMANCE_NUTS><VALUES_LIST/><REF_NOTICE><NO_DOC_OJS>2016/S 189-338056</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180118</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="1">Ministry or any other national or federal authority</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="V">Voluntary ex ante transparency notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><MA_MAIN_ACTIVITIES CODE="8">Other</MA_MAIN_ACTIVITIES><HEADING>01215</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Обединено кралство</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Противогрипни ваксини</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Spojené království/Velká Británie</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Očkovací látka proti chřipce</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Forenede Kongerige, Det</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Influenzavacciner</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>das Vereinigte Königreich</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Anti-Grippe-Impfstoffe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ηνωμένο Βασίλειο</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Αντιγριππικά εμβόλια</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>United Kingdom</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Influenza vaccines</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Reino Unido</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Vacunas contra la gripe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Suurbritannia / Ühendkuningriik</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Gripivastased vaktsiinid</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Yhdistynyt kuningaskunta</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Influenssarokotteet</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Royaume-Uni</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Vaccins antigrippe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Ríocht Aontaithe, an</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Influenza vaccines</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Ujedinjena Kraljevina</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Cjepiva protiv gripe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Egyesült Királyság</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Influenzavakcinák</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Regno Unito</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Vaccini antinfluenzali</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Jungtinė Karalystė, Didžioji Britanija</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Gripo vakcinos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Apvienotā Karaliste</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Gripas vakcīnas</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Ir-Renju Unit</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Vaċċini ta' l-influwenza</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Verenigd Koninkrijk</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Griepvaccins</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Zjednoczone Królestwo</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Sczepionki przeciw grypie</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Reino Unido</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Vacinas antigripe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Regatul Unit</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Vaccinuri antigripale</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Spojené kráľovstvo</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Očkovacie látky proti chrípke</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Združeno kraljestvo</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Cepiva proti gripi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Förenade kungariket</TI_CY><TI_TOWN>Runcorn</TI_TOWN><TI_TEXT>Influensavaccin</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="EN">The Secretary of State for Health acting as part of the Crown through the Department of Health)</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><VOLUNTARY_EX_ANTE_TRANSPARENCY_NOTICE CATEGORY="ORIGINAL" FORM="15" LG="EN" VERSION="R2.0.8.S03.E01"><FD_VOLUNTARY_EX_ANTE_TRANSPARENCY_NOTICE CTYPE="SUPPLIES"><NOTICE_PUBLISHED NOTICE="CONTRACTING_AUTHORITY"/><CONTRACTING_AUTHORITY_VEAT><NAME_ADDRESSES_CONTACT_VEAT><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>The Secretary of State for Health acting as part of the Crown through the Department of Health)</OFFICIALNAME></ORGANISATION><ADDRESS>2nd Floor, Rutland House</ADDRESS><TOWN>Runcorn</TOWN><POSTAL_CODE>WA7 2ES</POSTAL_CODE><COUNTRY VALUE="UK"/><ATTENTION>Nichols Lynne</ATTENTION><E_MAILS><E_MAIL>lynne.nichols@dh.gsi.gov.uk</E_MAIL></E_MAILS></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_VEAT><URL_GENERAL>https://cmu.bravosolution.co.uk</URL_GENERAL><URL_INFORMATION>https://cmu.bravosolution.co.uk</URL_INFORMATION></INTERNET_ADDRESSES_VEAT></NAME_ADDRESSES_CONTACT_VEAT><TYPE_AND_ACTIVITIES_OR_CONTRACTING_ENTITY_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="MINISTRY"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/><TYPE_OF_ACTIVITY_OTHER VALUE="OTHER">Procurement</TYPE_OF_ACTIVITY_OTHER></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF><PURCHASING_ON_BEHALF_YES><CONTACT_DATA_OTHER_BEHALF_CONTRACTING_AUTORITHY><ORGANISATION><OFFICIALNAME>Please reference VI.2 Additional Information of this notice</OFFICIALNAME></ORGANISATION></CONTACT_DATA_OTHER_BEHALF_CONTRACTING_AUTORITHY></PURCHASING_ON_BEHALF_YES></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_OR_CONTRACTING_ENTITY_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_VEAT><OBJECT_VEAT><DESCRIPTION_VEAT><TITLE_CONTRACT><P>Contract for the supply of live attenuated intranasal influenza vaccine</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION><TYPE_CONTRACT VALUE="SUPPLIES"/><TYPE_SUPPLIES_CONTRACT VALUE="PURCHASE"/></TYPE_CONTRACT_LOCATION><LOCATION_NUTS><LOCATION><P>Bedford, UK</P></LOCATION><n2016:NUTS CODE="UK"/></LOCATION_NUTS><SHORT_CONTRACT_DESCRIPTION><P>The provision of a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. Deliveries will be required from 1.8.2018 to 31.7.2020 with an option to extend for up to an additional 24 months.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33651660"/></CPV_MAIN><CPV_ADDITIONAL><CPV_CODE CODE="33651600"/></CPV_ADDITIONAL></CPV><CONTRACT_COVERED_GPA VALUE="YES"/></DESCRIPTION_VEAT></OBJECT_VEAT><PROCEDURE_DEFINITION_VEAT><TYPE_OF_PROCEDURE_DEF_F15><F15_PT_NEGOTIATED_WITHOUT_COMPETITION><ANNEX_D_F15><ANNEX_D1><JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><REASONS_PROVIDED_PARTICULAR_TENDERER><REASONS_PROVIDED_PARTICULAR_TENDERER_TECHNICAL/></REASONS_PROVIDED_PARTICULAR_TENDERER></JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><REASON_CONTRACT_LAWFUL><P>There is only one manufacturer of this vaccine approved for use in the UK, therefore using the negotiated procedure without prior publication is justified under Regulation 32 (2)(b)(ii) of the Publics Contracts Regulations 2015.</P></REASON_CONTRACT_LAWFUL></ANNEX_D1></ANNEX_D_F15></F15_PT_NEGOTIATED_WITHOUT_COMPETITION></TYPE_OF_PROCEDURE_DEF_F15><AWARD_CRITERIA_VEAT_INFORMATION><AWARD_CRITERIA_DETAIL_F15><MOST_ECONOMICALLY_ADVANTAGEOUS_TENDER_SHORT/></AWARD_CRITERIA_DETAIL_F15><F15_IS_ELECTRONIC_AUCTION_USABLE VALUE="NO"/></AWARD_CRITERIA_VEAT_INFORMATION><ADMINISTRATIVE_INFORMATION_VEAT><FILE_REFERENCE_NUMBER><P>CM/PHV/14/5433</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F15><PREVIOUS_PUBLICATION_EXISTS_F15><PREVIOUS_PUBLICATION_NOTICE_F15><PREVIOUS_NOTICE_BUYER_PROFILE_F15 CHOICE="PRIOR_INFORMATION_NOTICE"/><NOTICE_NUMBER_OJ>2016/S 189-338056</NOTICE_NUMBER_OJ><DATE_OJ><DAY>30</DAY><MONTH>09</MONTH><YEAR>2016</YEAR></DATE_OJ></PREVIOUS_PUBLICATION_NOTICE_F15></PREVIOUS_PUBLICATION_EXISTS_F15></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F15></ADMINISTRATIVE_INFORMATION_VEAT></PROCEDURE_DEFINITION_VEAT><AWARD_OF_CONTRACT_DEFENCE><CONTRACT_NUMBER>CM/PHV/14/5433</CONTRACT_NUMBER><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>AstraZeneca UK Ltd</OFFICIALNAME></ORGANISATION><ADDRESS>1 Francis Crick Avenue</ADDRESS><TOWN>Cambridge</TOWN><POSTAL_CODE>CB2 0AA</POSTAL_CODE><COUNTRY VALUE="UK"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS></AWARD_OF_CONTRACT_DEFENCE><COMPLEMENTARY_INFORMATION_VEAT><RELATES_TO_EU_PROJECT_NO/><ADDITIONAL_INFORMATION><P>Other contracting authorities.</P><P>The contract is for the benefit of the Contracting Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non departmental.</P><P>Public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.</P></ADDITIONAL_INFORMATION><NOTICE_DISPATCH_DATE><DAY>18</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_VEAT></FD_VOLUNTARY_EX_ANTE_TRANSPARENCY_NOTICE></VOLUNTARY_EX_ANTE_TRANSPARENCY_NOTICE></FORM_SECTION></TED_EXPORT>